Cafeity Get the app

Everyday life

Habits to keep after stopping a GLP-1

People stop GLP-1 medicines for many reasons — cost, side effects, supply, pregnancy plans, a decision made with their prescriber. Appetite usually comes back, and the trials are clear that weight often does too. Nobody has yet shown a set of habits that prevents that. But some habits are linked with keeping weight off in other research, and most are worth having for their own sake.

By the Cafeity teamUpdated 5 min read

The short answer

Plan stopping with your prescriber. When GLP-1 medicines are stopped, weight regain is common — typically nearly back to baseline within a year — and structured lifestyle programmes to prevent it have not yet been tested in controlled trials.1 Habits associated with keeping weight off in other research include about an hour of physical activity a day, self-monitoring weight and food, regular meals and support from other people.12 Keeping up protein and strength training helps protect muscle.

Bar chart of two trials that stopped treatment. In the STEP 1 extension, the group lost an average of 17.3% of body weight on semaglutide over 68 weeks, and a year after stopping was a net 5.6% below where they started. In SURMOUNT-4, everyone lost 20.9% in a 36-week lead-in on tirzepatide; those who continued lost a further 5.5%, while those switched to placebo regained 14%.
Averages from two trials, not predictions for any one person. Stopping treatment, without other support, was followed by substantial regain in both.Chart: Cafeity, from the STEP 1 extension (2022) and SURMOUNT-4 (2024).

What the trials show after stopping

In the STEP 1 trial extension, 327 adults stopped semaglutide — and the trial's lifestyle programme — after 68 weeks, having lost an average of 17.3% of their body weight. A year later they had regained two-thirds of what they lost, and most of the improvements in heart and metabolic risk factors had drifted back towards where they started.3

In SURMOUNT-4, everyone took tirzepatide for 36 weeks and then was randomised to continue or switch to placebo. Those switched to placebo regained 14% of their body weight over the following year, while those who continued lost a further 5.5%.4

The 2025 joint advisory sums it up: when GLP-1 medicines are stopped, regain is common, typically nearly to baseline within one year, even with conventional nutrition counselling or behavioural therapy — and more intensive, structured programmes to prevent it have not yet been studied.1 That is worth knowing before anyone promises you otherwise.

Plan stopping with your prescriber

  • Agree the reason and the plan: when to stop, and what follow-up you will have afterwards.
  • Ask what to watch: your weight trend, and any blood pressure, blood sugar or other measures that improved on treatment.
  • Agree a review point — a change in weight or health that would prompt a conversation about what next.
  • If you are planning a pregnancy, the semaglutide label advises stopping at least 2 months beforehand; see contraception and pregnancy.5

For what happens to appetite and weight in more detail, see stopping a GLP-1.

Habits linked with keeping weight off

The evidence here comes from people who kept weight off in other settings — most of it from before these medicines existed — so it shows what successful maintainers do, not what is proven to work after a GLP-1. The National Weight Control Registry, for example, follows people who lost an average of 33 kg and kept it off for more than five years.2

Associations, not guarantees.
HabitWhat the research saysOne way to keep it
Daily activityRegistry members report about an hour of physical activity a day; the joint advisory lists 60+ minutes a day among behaviours associated with long-term maintenance.21Walk at the same time every day; see walking more
Self-monitoringSelf-monitoring of body weight, food intake and activity is on the advisory's list; registry members self-monitor their weight.12Weigh at the same time each week and watch the trend
Regular mealsRegistry members eat breakfast regularly and keep a consistent eating pattern on weekdays and weekends.2Keep the meal times you built on treatment
Less screen timeThe advisory lists limiting screen time to under 10 hours a week.1Swap one evening of screens for a walk or a class
Coping strategiesSocial support, advance planning and problem-solving skills are on the advisory's list.1Plan the hard situations — holidays, stress, travel — before they arrive
Strength and proteinThe advisory recommends strength training and adequate protein to preserve muscle and bone.1Keep the strength week going

One encouraging finding from the registry: maintenance seemed to get easier with time, and people who had kept weight off for 2 to 5 years had a much better chance of continuing to.2

When appetite and food noise come back

Appetite and food noise often return as the medicine leaves your system over the following weeks. Expect it rather than treating it as a failure. Structure helps: regular meals with protein first, fibre-rich foods, and a plan for the times of day you are hungriest. If food noise is loud, write down when and where it shows up; see food noise and the journal prompts.

Support and follow-up

The joint advisory points to supportive approaches such as group-based visits, counselling with a registered dietitian nutritionist, and telehealth and digital programmes.1 Ask your prescriber what is available to you. And if you restart treatment later, ask how: the labels have rules for restarting after missed doses — the semaglutide label, for example, says that after two or more missed doses in a row, treatment is restarted at a lower dose to reduce the risk of stomach side effects.5

Keeping a record of it

Keep logging after you stop. Cafeity's weight trend shows direction rather than daily noise, and nothing you have recorded is deleted if your plan changes — your treatment history stays with you for the next conversation with your prescriber.

Cafeity weight screen showing a smoothed trend weight of 115.6 kg, down 5.5 kg since last week, with the note "Based on your recent rate. Not a prediction."
The trend, not the daily number.
Cafeity Visit Summary set-up: a period picker (4 weeks, 3 months, 6 months, custom) and switches for medication and doses, weight trend, body measurements, symptoms, protein and energy, activity and sleep, and notes tagged for the prescriber.
Your history, for the next appointment.

Screenshots: Cafeity for iPhone, version 1.1.

Download Cafeity on the App Store

Common questions

Will I regain weight after stopping a GLP-1?
Many people do. The 2025 joint advisory says regain is common, typically nearly to baseline within a year, and in the STEP 1 extension people regained two-thirds of their loss a year after stopping.13 Individual results vary.
Can habits prevent weight regain after a GLP-1?
It has not been shown yet. Structured lifestyle programmes to prevent regain after stopping have not been tested in controlled trials.1 Habits linked with maintenance in other research are still worth keeping.
What habits help keep weight off?
In the National Weight Control Registry: about an hour of activity a day, eating breakfast regularly, self-monitoring weight and a consistent eating pattern on weekdays and weekends.2
Should I keep strength training after stopping?
Yes. The joint advisory recommends strength training and enough protein to help preserve muscle and bone.1
Can I restart a GLP-1 after stopping?
Ask your prescriber. The labels have specific rules for restarting after missed doses; the semaglutide label says that after two or more missed doses in a row, treatment restarts at a lower dose.5

Sources

  1. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society Mozaffarian D et al. 2025 (published in four journals)
  2. Long-term weight loss maintenance (findings from the National Weight Control Registry) Wing RR, Phelan S. American Journal of Clinical Nutrition 2005;82(1 Suppl):222S–225S
  3. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension Wilding JPH et al. Diabetes, Obesity and Metabolism 2022;24:1553–1564
  4. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4) Aronne LJ et al. JAMA 2024;331(1):38–48
  5. Semaglutide injection and tablets for weight management — US prescribing information DailyMed, US National Library of Medicine, version published 30 June 2026

Written by the Cafeity team from the sources listed here. Figures from prescribing information are quoted as the label states them; trial results are averages from those trials, not predictions for any one person. This page has not yet been reviewed by a clinician — see the editorial policy for how pages are researched and corrected.